Loading…
The company has expanded its market reach with new sales in China.
VivoSim Labs, INC. (Nasdaq: VIVS) announced the commencement of its first commercial sales in China for its NAMkind Testing Services. This development marks a significant expansion of the company's market presence in the biotechnology sector.
The announcement was made without specific financial figures or comparative data. VivoSim Labs, INC. has a free float of 2,325,676 shares and 3,494,071 shares outstanding.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.